Ozempic and Wegovy Ease Knee Osteoarthritis Pain in Large Study
A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current medications in alleviating symptoms.
Read more at The New York Times
Topics
-
Ozempic reduces knee osteoarthritis pain by almost half: Study
Politics - The Hill - October 31 -
Ozempic and Wegovy may be beneficial in fighting alcohol addiction: Study
Politics - The Hill - November 14 -
Semaglutide linked to reduced arthritis knee pain in people with obesity, study finds
Top stories - NBC News - October 30 -
Ozempic and Wegovy considered 'available' after more than 2 years in shortage
Politics - The Hill - October 30 -
The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research
Top stories - CBS News - November 4 -
How a love story launched the company behind Ozempic, Wegovy
Top stories - CBS News - November 3 -
Ozempic, Wegovy popularity leads to rise of fake weight loss drugs
Top stories - CBS News - November 9 -
Ozempic can lead to muscle mass loss: Study
Politics - The Hill - November 9
More from The New York Times
-
Trump Chooses Dr. David Weldon, a Former Congressman, to Lead the C.D.C.
Health - The New York Times - 17 hours ago -
Alcohol Deaths Have More Than Doubled in Two Decades, Study Finds
Health - The New York Times - Yesterday -
Can RFK Jr. Limit Ozempic Access as HHS Chief? Here’s What to Know
Health - The New York Times - Yesterday -
Drug Overdose Deaths Are Declining Due to Changes in the Drug Supply
Health - The New York Times - 2 days ago -
Orders for Morning-After Pills and Abortion Pills Rise After Trump’s Election
Health - The New York Times - 4 days ago